Loading content…
Affiliate-supportedIndependent editorialWe never sell medicationSee how
South · District of Columbia
Local context for Wegovy, Ozempic, Mounjaro, and Zepbound in Washington (680,000 residents, 6,390,000 metro). DC Medicaid covers GLP-1s for T2D with prior auth; federal employee health benefits dominate local commercial coverage.
Availability and prices vary by pharmacy and date. We do not maintain real-time per-pharmacy stock data. Confirm with pharmacies directly.
Wegovy
semaglutide · Novo Nordisk
Once-weekly semaglutide injection FDA-approved for chronic weight management in adults and adolescents.
Wegovy in Washington →
Ozempic
semaglutide · Novo Nordisk
Once-weekly semaglutide injection FDA-approved for adults with type 2 diabetes.
Ozempic in Washington →
Mounjaro
tirzepatide · Eli Lilly
Once-weekly tirzepatide injection FDA-approved for adults with type 2 diabetes.
Mounjaro in Washington →
Zepbound
tirzepatide · Eli Lilly
Once-weekly tirzepatide injection FDA-approved for chronic weight management and obstructive sleep apnea.
Zepbound in Washington →
Washington is a south-region city with a population of 680,000 (6,390,000 in the broader metropolitan area). District of Columbia expanded Medicaid under the Affordable Care Act, which means low-income adults can typically qualify for GLP-1 coverage for type 2 diabetes if the state Medicaid program lists the drug.
Statewide, notable health systems include MedStar Health, GW Hospital, Children's National.
District of Columbia's Medicaid program is DC Medicaid. Coverage rules for GLP-1 medications vary by drug and indication; see our pricing by state map and payer-coverage guides for details.
Cities of similar size with comparable healthcare markets.